In a small case-control study examining 46 NAFLD Turks, C3 levels were significantly higher in NAFLD patients compared with healthy controls, and C3 activity correlated with disease severity [13]. This evidence concerns the gene C3 and metabolic dysfunction-associated steatotic liver disease.